Orai1通道抑制可保持左心室缩功能和压力过载后正常的Ca2+处理
Fiona Bartoli1, Marc A Bailey2, Baptiste Rode2
1Inserm, UMR-S 1180, Signalisation et Physiopathologie Cardiovasculaire, Université Paris-Saclay, Châtenay-Malabry, France (F.B., P.M., K.B., P.G., S.G., F.L., A.-M.G., J.P.B., J. Sabourin).
Circulation
|January 8, 2020
概括
心脏Orai1通道是高和心力衰竭的关键. 抑制Orai1可以防止心脏功能障碍,并保持高压缩后的收缩性,这表明Orai1抑制剂是潜在的治疗方法.
科学领域:
- 心血管研究研究心血管研究
- 离子通道生理学 离子通道生理学
- 分子心脏病学分子心脏病学
背景情况:
- Orai1调解储存的Ca2+进入 (SOCE),在不可刺激的细胞中至关重要.
- SOCE越来越多地与心脏缩和心力衰竭有关.
- 对于Orai1在心脏病理生理学的具体作用尚不清楚.
研究的目的:
- 研究Orai1通道在心脏缩和功能障碍中的作用.
- 在心脏缩的小鼠模型中评估Orai1抑制的治疗潜力.
主要方法:
- 生成了一个心肌细胞特异的Orai1敲击鼠标模型 (C-dnO1).
- 在体内研究中使用小分子Orai1抑制剂 (JPIII).
- 在小鼠中通过横向大动脉收缩 (TAC) 诱导的心脏缩.
主要成果:
- TAC诱导心脏缩,功能障碍,并增加了Orai1依赖的SOCE.
- C-dnO1小鼠受到TAC诱导的缩功能障碍和心脏Ca2+信号改变的保护.
- 通过JPIII抑制Orai1也显示出对过度缩性损伤的保护作用.
结论:
- 心脏Orai1通道在心脏缩和功能障碍的发展中起着至关重要的作用.
- 抑制Orai1代表了一种有前途的治疗策略,用于在过度缩压力下保持心脏收缩性.
相关概念视频
Antihypertensive Drugs: Action of Calcium Channel Blockers
1.4K
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
1.4K
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
1.5K
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
1.5K
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
1.2K
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
1.2K
Cardiomyopathy IV: Restrictive Cardiomyopathy
396
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
396
Feedback Regulation of Calcium Concentration
3.8K
Calcium is an essential signaling molecule required for various cellular functions. Calcium pumps and ion channels on cell and organellar membranes, such as those on the endoplasmic reticulum (ER), regulate calcium concentrations inside the cell. They remain closed, keeping the cytosolic calcium levels low at a resting state.
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
3.8K
Heart Failure II: Pathophysiology
612
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
612


